A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer

Abstract Background Transoral surgery (TOS) has been widely applied for early T‐stage head and neck cancer (HNC). The resection is performed with a minimum safety margin for function preservation under a limited surgical field; therefore, it is difficult to have a strong conviction about the complet...

Full description

Bibliographic Details
Main Authors: Goshi Nishimura, Daisuke Sano, Yasuhiro Arai, Takashi Hatano, Hideaki Takahashi, Teruhiko Tanabe, Takashi Wada, Daiki Morishita, Nobuhiko Oridate
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.2588
_version_ 1818389065022570496
author Goshi Nishimura
Daisuke Sano
Yasuhiro Arai
Takashi Hatano
Hideaki Takahashi
Teruhiko Tanabe
Takashi Wada
Daiki Morishita
Nobuhiko Oridate
author_facet Goshi Nishimura
Daisuke Sano
Yasuhiro Arai
Takashi Hatano
Hideaki Takahashi
Teruhiko Tanabe
Takashi Wada
Daiki Morishita
Nobuhiko Oridate
author_sort Goshi Nishimura
collection DOAJ
description Abstract Background Transoral surgery (TOS) has been widely applied for early T‐stage head and neck cancer (HNC). The resection is performed with a minimum safety margin for function preservation under a limited surgical field; therefore, it is difficult to have a strong conviction about the complete resection. This study aims to evaluate the completeness of the initial TOS procedure; possibility of primary control by TOS alone; and predictive factors in patients with early T‐stage laryngeal, oropharyngeal, and hypopharyngeal cancer. Methods Patients were treated by TOS at the primary site with or without neck dissection. The patients were divided into two groups based on the pathological evaluation of their surgical specimens: the control (observation) group, in that the resection was considered complete and the intervention (second‐look procedure) group, in that incomplete tumor resection was suspected. The predictive factors for the possibility and/or limitations of complete resection by TOS were then analyzed. Results The study enrolled 26 and 25 patients in the control and intervention group, respectively. The success rate for single resection was 66% and the predictive factor was tumor depth obtained by enhanced computed tomography (CT) examination (odds ratio, 7.870, P = .0243). The success rate for definitive therapy by TOS alone was 83% and the predictive factor was poor differentiation observed on pathological examination (odds ratio, 6.800, P = .0248). Conclusions TOS has the potential for both definitive resection and function preservation with minimal invasiveness. Identification of the risk factors for TOS is advantageous for accurate treatment selection in patients with early T‐stage HNC.
first_indexed 2024-12-14T04:35:48Z
format Article
id doaj.art-6f086c5140a24a27a48c40f2c5d6a6c6
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-12-14T04:35:48Z
publishDate 2019-12-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-6f086c5140a24a27a48c40f2c5d6a6c62022-12-21T23:16:58ZengWileyCancer Medicine2045-76342019-12-018177197720610.1002/cam4.2588A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancerGoshi Nishimura0Daisuke Sano1Yasuhiro Arai2Takashi Hatano3Hideaki Takahashi4Teruhiko Tanabe5Takashi Wada6Daiki Morishita7Nobuhiko Oridate8Department of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanDepartment of Otorhinolaryngology, Head and Neck Surgery School of Medicine Yokohama City University Yokohama JapanAbstract Background Transoral surgery (TOS) has been widely applied for early T‐stage head and neck cancer (HNC). The resection is performed with a minimum safety margin for function preservation under a limited surgical field; therefore, it is difficult to have a strong conviction about the complete resection. This study aims to evaluate the completeness of the initial TOS procedure; possibility of primary control by TOS alone; and predictive factors in patients with early T‐stage laryngeal, oropharyngeal, and hypopharyngeal cancer. Methods Patients were treated by TOS at the primary site with or without neck dissection. The patients were divided into two groups based on the pathological evaluation of their surgical specimens: the control (observation) group, in that the resection was considered complete and the intervention (second‐look procedure) group, in that incomplete tumor resection was suspected. The predictive factors for the possibility and/or limitations of complete resection by TOS were then analyzed. Results The study enrolled 26 and 25 patients in the control and intervention group, respectively. The success rate for single resection was 66% and the predictive factor was tumor depth obtained by enhanced computed tomography (CT) examination (odds ratio, 7.870, P = .0243). The success rate for definitive therapy by TOS alone was 83% and the predictive factor was poor differentiation observed on pathological examination (odds ratio, 6.800, P = .0248). Conclusions TOS has the potential for both definitive resection and function preservation with minimal invasiveness. Identification of the risk factors for TOS is advantageous for accurate treatment selection in patients with early T‐stage HNC.https://doi.org/10.1002/cam4.2588early T‐stage head and neck cancerlocoregional controlpredictive factorssecond‐look proceduretransoral surgery
spellingShingle Goshi Nishimura
Daisuke Sano
Yasuhiro Arai
Takashi Hatano
Hideaki Takahashi
Teruhiko Tanabe
Takashi Wada
Daiki Morishita
Nobuhiko Oridate
A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
Cancer Medicine
early T‐stage head and neck cancer
locoregional control
predictive factors
second‐look procedure
transoral surgery
title A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
title_full A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
title_fullStr A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
title_full_unstemmed A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
title_short A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
title_sort prospective clinical trial of the second look procedure for transoral surgery in patients with t1 and t2 laryngeal oropharyngeal and hypopharyngeal cancer
topic early T‐stage head and neck cancer
locoregional control
predictive factors
second‐look procedure
transoral surgery
url https://doi.org/10.1002/cam4.2588
work_keys_str_mv AT goshinishimura aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT daisukesano aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT yasuhiroarai aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT takashihatano aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT hideakitakahashi aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT teruhikotanabe aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT takashiwada aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT daikimorishita aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT nobuhikooridate aprospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT goshinishimura prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT daisukesano prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT yasuhiroarai prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT takashihatano prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT hideakitakahashi prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT teruhikotanabe prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT takashiwada prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT daikimorishita prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer
AT nobuhikooridate prospectiveclinicaltrialofthesecondlookprocedurefortransoralsurgeryinpatientswitht1andt2laryngealoropharyngealandhypopharyngealcancer